Over 537 million adults worldwide grapple with diabetes, with 3 in 4 residing in low- and middle-income countries. Shockingly, diabetes claimed 6.7 million lives in 2021 alone.

Docplexus’ Global Diabetes Summit 2023 aims to enhance access to vital medical information for doctors in remote areas, empowering them with cutting-edge knowledge for superior patient outcomes in diabetes care via best practices and latest updates from KOLs.

Join us from November 14th to 16th, 2023, for enlightening events with global experts in the diabetes space. Our Global Diabetes Summit is the pinnacle of diabetes-focused events, offering unparalleled opportunities to elevate your brand’s reach, engage with diabetologists and endocrinologists, and gain maximum exposure in the ever-evolving healthcare landscape.

8

Topics

15

Speakers

3000+

Verified Reach

8 Topics | 15 Speakers | 3000+ verified Reach

Position your healthcare brand at the forefront of the diabetes landscape. To secure your spot and maximize your brand exposure during the Docplexus Global Diabetes Summit 2023, click here to request a call back.

Why Partner with Us?

Empowering Doctors with Cutting-Edge Knowledge

Event Dates and Schedule

3 PM IST

Diabetes Management Strategies: Bridging the Gap Between Guidelines and Real-World Practice

Dr. Rakesh Sahay
Dr. Atul Luthra
Dr. Kalpana Dash

5 PM IST

Diabeto-Onco: Case-based Discussions

Dr. Vaishali Deshmukh
Dr. Shehla Shaikh
Dr. Anish Behl
Dr. Chetan Deshmukh
Dr. Apar Kishor Ganti
Dr. Shailesh Bondarde

2-4 PM IST

New Dual GLP 1 & GIP Agonist Terzipatide in Management of Type 2 Diabetes

Dr. Joel Teelucksingh
Dr. Ihab El Tayeb

6 PM IST

Metabolic Surgery for Diabetes

Dr. Vikas Singhal

3 PM IST
  • Assessing the comparative effectiveness of GLP-1 receptor agonists versus SGLT2 inhibitors in type 2 diabetes

  • Efficacy and Safety of Semaglutide in Type 2 Diabetes

Dr. Kathija Mahmood
Dr. Supratik Bhattacharya

6 PM IST

New trends in Diabetes Management: Continuous Glucose Monitoring (CGM)

Gut Microbiomes in Diabesity

Dr. Kavitha Bhat
Dr. Usha Sriram

Expert Panel

Dr. Ihab El Tayab

Dr. Ihab El Tayab

Consultant Endocrinologist, Prime Hospital Al Warqa, Dubai

Dr. Vikas Singhal

Dr. Vikas Singhal

Senior Consultant – GI Surgery, GI Oncology & Bariatric Surgery, Institute of Digestive & Hepatobiliary Sciences, Medanta, Gurugram

Dr. Vaishali Deshmukh

Dr. Vaishali Deshmukh

Consultant & Head of Endocrinology, Deenanath Mangeshkar Hospital & Research Centre Director, Deshmukh Clinic & Research Centre, Pune

Dr. Kavita Bhat

Dr. Kavitha Bhat

Sr. Consultant - Paediatric Endocrinology, Aster Women & Children Bangalore, Aster CMI Bangalore, Aster RV Bangalore

Dr. Rakesh Sahay

Dr. Rakesh Sahay

Sr. Consultant Endocrinologist, Aster Prime Hospital, Hyderabad

Dr. Usha Sriram

Head of Diabetology & Endocrinology, VHS Hospital, Chennai

Dr. Kalpana Dash

Dr. Kalpana Dash

Sr. Consultant Endocrinologist & Diabetologist Narayan Health, Bilaspur

Dr. Atul Luthra

Dr. Atul Luthra

Director & HOD - Fortis, Gurgaon

Dr. Supratik Bhattacharya

Dr. Supratik Bhattacharya

Director, SKN Diabetes and Endocrine Centre, Kolkata

Dr. Kathija Mahmood

Dr. Kathija Mahmood

Sr, Specialist- Internal Medicine, Dubai Health Authority, Dubai

Dr. Shehla Shaikh

Dr. Shehla Shaikh

Consultant Endocrinologist, Prince Aly Khan Hospital, Saifee Hospital & Wockhardt Hospital, Mumbai

Dr. Anish Behl

Dr. Anish Behl

MD - General Medicine, DM – Endocrinology, Mysore

Dr. Chetan Deshmukh

Dr. Chetan Deshmukh

MD, DNB - Internal Medicine, BJMC & Sassoon General Hospital, Pune & DM (Medical Oncology), Tata Memorial Hospital, Bangalore

Dr. Apar Kishor Ganti

Dr. Apar Kishor Ganti

Associate Director, Clinical Research, UNMC, Fred & Pamela Buffett Cancer Center, United States

Dr. Shailesh Bondarde

Dr. Shailesh Bondarde

MD, Fellow Medical Oncology, Tata Memorial Hospital, Mumbai

Discover Our Renowned Leaders in Diabetes Care

    Highlights from Global Diabetes Summit 2022 👇

    Pharma Marketing Challenges:
    Share answer through form.

    How would you bring the attention of your target doctors in this scenario?

    You have a legacy molecule in the management of uncontrolled Type 2 Diabetes. You are facing issues from the target doctors since there are newer molecules and uptake is better there. You are covering Endos & Diabetos with your Field Force. How would you bring the attention of your target doctors in this scenario?

    How will you overcome the existing position of the drug in the market?

    You are a Pharma company which has a product in the weight loss area. But over the years the company has only gained a nominal market share. The strategy team has decided to position the product in Diabetes space as the main indication and weight loss as minor indication. How will you help to market this idea to the HCPs? How will you overcome the existing position of the drug in the market?

    How will you prove your product’s efficacy?

    In a crowded anti-diabetic landscape, you take a bold step to enter the competitive diabetes market. With established players already ruling the roost and doctors accustomed to prescribing their trusted brands, you will face an enormous challenge. Amidst fierce competition how will you prove your product’s efficacy, create brand awareness, establish a foothold in the doctor’s mind and thereby influence their intent to prescribe?

    How will you learn the current perception of your brand by HCPs?

    You have a well-established anti-diabetic brand and for years it has been a trusted name among HPCs. However, the once-soaring profits have now begun to plateau. Despite the efforts, the sales representatives, the frontline connection with HCPs, couldn’t provide any insights into this stagnation. How will you learn the current perception of your brand by HCPs? What do the HCPs want? What are their interest areas? What treatment options are they looking at?

    Should they invest in a digital marketing plan?

    A new department of diabetology of well-established company has reached an impasse regarding their sales strategy. In the current situation the company is relying mostly on the dealers appointed in different locations for their sales. But the dealers are a little reluctant to push their products given the nascent phase of the department. Should the company invest in hiring new sales reps for better penetration in the HCP space or should they invest in a digital marketing plan?

    Is there a way to increase the uptake of the other two medicines?

    In the competitive realm of diabetes medications, you are in a unique situation. Among your trio of diabetes drugs, one, Medicine A, shone brightly, capturing the attention of doctors. Unfortunately, Medicines B and C, though effective, remained in the background. The challenge lay in the brief 2-minute window the sales reps had with doctors, allowing discussion about only one medicine. This left the other two silently waiting and their potential untapped. Is there a way to increase the uptake of the other two medicines? Should you consider trying some other communication channel for the other two drugs?

    How do you access this non-metro market?

    With 16.1% prevalence of diabetes in urban India, one of the leading pharma companies found success in metropolitan cities where their diligent sales representatives worked tirelessly. Their products were well-known among city doctors, leading to booming sales. However, beyond the cityscape, numerous doctors in non-metro cities remained untouched because there were no sales reps assigned there. This untapped potential represented a significant loss, as sales opportunities slipped away in regions where the company could have flourished. How do you access this non-metro market?

    Comments